Low-saturated-fat and low-cholesterol diet does not alter pubertal development and hormonal status in adolescents.


Journal

Acta paediatrica (Oslo, Norway : 1992)
ISSN: 1651-2227
Titre abrégé: Acta Paediatr
Pays: Norway
ID NLM: 9205968

Informations de publication

Date de publication:
02 2019
Historique:
received: 01 02 2018
revised: 19 04 2018
accepted: 26 06 2018
pubmed: 29 6 2018
medline: 11 4 2020
entrez: 29 6 2018
Statut: ppublish

Résumé

The aim was to assess the influence of dietary counselling on the pubertal development and hormonal status in healthy adolescents. We used a subcohort of 193 healthy boys (52%) and girls (48%) from the Special Turku Coronary Risk Factor Intervention Project. Participants were recruited by nurses at the well-baby clinics in Turku Finland in 1990-1992 and randomised into intervention and control groups. Intervention children received low-saturated fat and low-cholesterol dietary counselling initiated at seven months of age. Participants were examined once a year with Tanner staging, anthropometric measurements and serial reproductive hormones from 10 to 19 years of age. In girls, postmenarcheal hormones were not analysed. Pubertal hormones in boys or girls did not differ between the intervention and control groups. However, we observed slight differences in pubertal progression by Tanner staging and in anthropometric parameters. The intervention boys progressed faster to G4 (p = 0.008), G5 (p = 0.008) and P5 (p = 0.03). The intervention boys were taller than control boys (p = 0.04), while weight and body mass index did not differ. Dietary intervention did not affect pubertal hormonal status. This finding supports the safety of implemented counselling in respect to puberty.

Identifiants

pubmed: 29953705
doi: 10.1111/apa.14480
pmc: PMC6586057
doi:

Substances chimiques

Hormones 0
Cholesterol 97C5T2UQ7J

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

321-327

Subventions

Organisme : Academy of Finland
ID : 251360
Pays : International
Organisme : Academy of Finland
ID : 276861
Pays : International
Organisme : Academy of Finland
ID : 253341
Pays : International
Organisme : Academy of Finland
ID : 258497
Pays : International
Organisme : Academy of Finland
ID : 308065
Pays : International
Organisme : Academy of Finland
ID : 307996
Pays : International
Organisme : Sigrid Juselius Foundation
Pays : International
Organisme : Turku University Hospital Special Governmental Grant
Pays : International
Organisme : Foundation for Pediatric Research
Pays : International
Organisme : Novo Nordisk Foundation
ID : NNF16OC0021302
Pays : International

Informations de copyright

©2018 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.

Références

J Natl Cancer Inst. 1999 Mar 17;91(6):529-34
pubmed: 10088623
J Clin Endocrinol Metab. 2006 Oct;91(10):3992-6
pubmed: 16868056
Prog Cardiovasc Nurs. 2003 Winter;18(1):28-41
pubmed: 12624570
Circulation. 2013 May 28;127(21):2088-96
pubmed: 23613255
Circulation. 2005 Dec 13;112(24):3786-94
pubmed: 16330680
Pediatr Nephrol. 2012 Sep;27(9):1441-52
pubmed: 21877168
J Natl Cancer Inst. 2003 Jan 15;95(2):132-41
pubmed: 12529346
J Clin Endocrinol Metab. 2010 Jan;95(1):263-70
pubmed: 19926714
Hypertension. 2009 Jun;53(6):918-24
pubmed: 19364991
Lancet. 1995 Feb 25;345(8948):471-6
pubmed: 7861873
Pediatrics. 2008 Feb;121 Suppl 3:S218-30
pubmed: 18245514
Endocr Rev. 2003 Oct;24(5):668-93
pubmed: 14570750
J Clin Endocrinol Metab. 1999 Oct;84(10):3666-72
pubmed: 10523012
Acta Paediatr. 2010 Jun;99(6):888-95
pubmed: 20002624
Am J Clin Nutr. 1996 Dec;64(6):850-5
pubmed: 8942407
Int J Epidemiol. 2009 Jun;38(3):650-5
pubmed: 18430753
Am J Clin Nutr. 2010 Mar;91(3):651-61
pubmed: 20071642
Pediatrics. 2002 Nov;110(5):903-10
pubmed: 12415028
Pediatrics. 2012 Mar;129(3):e704-13
pubmed: 22331346
Circulation. 2007 Aug 28;116(9):1032-40
pubmed: 17698729
Circulation. 2015 Feb 17;131(7):605-13
pubmed: 25605660
Diabetes Care. 2013 Oct;36(10):2952-9
pubmed: 23801725
Arch Pediatr Adolesc Med. 2001 Sep;155(9):1022-8
pubmed: 11529804

Auteurs

Sergey Sadov (S)

Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.

Helena E Virtanen (HE)

Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.

Katharina M Main (KM)

Department of Growth and Reproduction and EDMaRC, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Anna-Maria Andersson (AM)

Department of Growth and Reproduction and EDMaRC, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Anders Juul (A)

Department of Growth and Reproduction and EDMaRC, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Antti Jula (A)

The Research Centre of Applied and Preventive Cardiovascular Medicine, Department of Medicine, University of Turku, Turku, Finland.
Division of Medicine, Turku University Hospital, Turku, Finland.

Olli T Raitakari (OT)

The Research Centre of Applied and Preventive Cardiovascular Medicine, Department of Medicine, University of Turku, Turku, Finland.
Division of Medicine, Turku University Hospital, Turku, Finland.

Katja Pahkala (K)

The Research Centre of Applied and Preventive Cardiovascular Medicine, Department of Medicine, University of Turku, Turku, Finland.
Paavo Nurmi Centre, Sports and Exercise Medicine Unit, Department of Health and Physical Activity, University of Turku, Turku, Finland.

Harri Niinikoski (H)

Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
Department of Paediatrics, Turku University Hospital, Turku, Finland.

Jorma Toppari (J)

Research Centre for Integrative Physiology and Pharmacology, Institute of Biomedicine, University of Turku, Turku, Finland.
Department of Paediatrics, Turku University Hospital, Turku, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH